Qu Cui

Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study

Yongxian Hu, Yali Zhou, Mingming Zhang et al. · Cell Research · 2022 · 190 citations · Full text

Medicine, Hematology, Immunology +16

Potent Anti-leukemia Activities of Chimeric Antigen Receptor–Modified T Cells against CD19 in Chinese Patients with Relapsed/Refractory Acute Lymphocytic Leukemia

Yongxian Hu, Zhao Wu, Yi Luo et al. · Clinical Cancer Research · 2016 · 134 citations

Life Sciences, Oncology, Pharmacology +17

Glycolysis Inhibition Inactivates ABC Transporters to Restore Drug Sensitivity in Malignant Cells

Ayako Nakano, Daisuke Tsuji, Hirokazu Miki et al. · PLoS ONE · 2011 · 106 citations · Full text

Medicine, Oncology, Pharmacology +17

Pre-transplant MRD negativity predicts favorable outcomes of CAR-T therapy followed by haploidentical HSCT for relapsed/refractory acute lymphoblastic leukemia: a multi-center retrospective study

Houli Zhao, Jieping Wei, Guoqing Wei et al. · Journal of Hematology & Oncology · 2020 · 83 citations · Full text

Medicine, Hematology, Oncology +16

Effect of smoking on lung function, respiratory symptoms and respiratory diseases amongst HIV-positive subjects: a cross-sectional study

Qu Cui, Sue Carruthers, Andrew McIvor et al. · AIDS Research and Therapy · 2010 · 78 citations · Full text

Public Health, Health Sciences, Population Health +16